Literature DB >> 6339437

Insulin growth factor and epidermal growth factor trigger mitosis in lenses cultured in a serum-free medium.

J R Reddan, D Wilson-Dziedzic.   

Abstract

The mitogenicity of insulin, insulin growth factor (IGF), and epidermal growth factor (EGF) was evaluated on rabbit lenses cultured in medium KEI-4. IGF, the most highly purified of the insulin-like growth factors was a potent mitogen for mammalian lens epithelia cells. IGF and EGF triggered cell proliferation throughout the normally amitotic central and pre-equatorial region of the epithelium. The mitotic response elicited by IGF and EGF was dose dependent, was preceded by DNA synthesis, exceeded that engendered by equimolar insulin, and exhibited a chronology identical to that brought about by crystalline insulin. Lenses cultured in KEI-4 alone or in KEI-4 supplemented with growth hormone, proinsulin, the A and/or B chain of insulin, or MSA, another of the insulin-like growth factors belonging to the somatomedin family, did not show a mitotic response. Simultaneous exposure of the lens to IGF and EGF resulted in an increase in the total number of mitotic figures over that obtained with equimolar concentrations of IGF and EGF. Our results suggest that IGF or other insulin-like growth factors may be capable of regulating cell division in the mammalian lens in vivo. That the lens epithelium responded to IGF and EGF may indicate that lens epithelial cells are subject to multiple hormonal interaction. Since growth factors appear to be cell type specific, information obtained from the rabbit lens epithelium should be useful in delineating the factors and conditions required for the growth of cultured human lens cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339437

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

1.  Lens thickness and insulin dependent diabetes mellitus: a population based twin study.

Authors:  N Løgstrup; A K Sjølie; K O Kyvik; A Green
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

2.  Time-specific blockade of PDGFR with Imatinib (Glivec®) causes cataract and disruption of lens fiber cells in neonatal mice.

Authors:  Yin-Pin Zhou; Yang-Tao He; Cheng-Li Chen; Jun Ji; Jian-Qin Niu; Han-Zhi Wang; Shi-Feng Li; Lan Huang; Feng Mei
Journal:  Virchows Arch       Date:  2010-12-23       Impact factor: 4.064

Review 3.  Cell cycle regulation in the developing lens.

Authors:  Anne E Griep
Journal:  Semin Cell Dev Biol       Date:  2006-11-01       Impact factor: 7.727

Review 4.  Understanding the role of growth factors in embryonic development: insights from the lens.

Authors:  F J Lovicu; J W McAvoy; R U de Iongh
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-04-27       Impact factor: 6.237

Review 5.  Somatomedins: chemical and functional characteristics of the different molecular forms.

Authors:  A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

6.  Sprouty2-modulated Kras signaling rescues Shp2 deficiency during lens and lacrimal gland development.

Authors:  Yi Pan; Christian Carbe; Andrea Powers; Gen-Sheng Feng; Xin Zhang
Journal:  Development       Date:  2010-04       Impact factor: 6.868

7.  Biometry of the crystalline lens in early-onset diabetes.

Authors:  J M Sparrow; A J Bron; N A Brown; H A Neil
Journal:  Br J Ophthalmol       Date:  1990-11       Impact factor: 4.638

8.  A new method for study of normal lens development in vitro using pulsatile delivery of PDGF or EGF in HL-1 serum-free medium.

Authors:  B Brewitt; J I Clark
Journal:  In Vitro Cell Dev Biol       Date:  1990-03

9.  Notch signaling is required for lateral induction of Jagged1 during FGF-induced lens fiber differentiation.

Authors:  Senthil S Saravanamuthu; Chun Y Gao; Peggy S Zelenka
Journal:  Dev Biol       Date:  2009-05-27       Impact factor: 3.582

10.  Age-dependent control of lens growth by hypoxia.

Authors:  Ying-Bo Shui; David C Beebe
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.